|
|
|
Press Releases
CHINA NATIONAL MEDICINES CORPORATION ISSUES MILESTONE PURCHASE
ORDER FOR 12,000 STA SYSTEMS
PISCATAWAY, N.J. – (PR NEWSWIRE) – November
2, 2009 – Milestone Scientific Inc. (OTCBB:MLSS),
the recognized leader in computer-controlled injection technologies,
today announced that it has received a blanket purchase order from
China National Medicines Corporation Ltd. for 12,000 STA Single
Tooth Anesthesia Systems™ (STA Systems), deliverable over
the next 36 months.
Leonard Osser, Chief Executive Officer of Milestone,
noted, “This
order serves both as validation of our award-winning technology and the
growing market acceptance of the STA System. Milestone has invested
significant effort over the last few months in the international arena,
and we are delighted to see our efforts begin to bear fruit.”
Traded on the Shanghai Stock Exchange (SHA:600511), China National Medicines
Corporation, d/b/a Sinopharm, is China’s largest domestic manufacturer,
distributor and marketer of pharmaceuticals and importer of medical devices,
and the country’s largest domestic distributor of local anesthetic
dental carpules to the dental profession in China today. In April
of this year, Milestone granted Sinopharm exclusive distribution and
marketing rights to the STA System in China. Prior to issuing
this blanket purchase order, Sinopharm’s orders to date have provided
for the shipment of 500 STA Systems and 500,000 related disposable
hand pieces to China.
According to a report published by the U.S. Department
of Commerce, titled “China’s Emerging Markets: Opportunities in the Dental
and Dental Lab Industry,” China’s dental market lags behind
other healthcare services and has largely been neglected in the past. In
fact, CS Market Research reports that “of China’s 1.3 billion
plus population, 50% of the adults and 70% of the children are estimated
to have decayed tooth problems, and over 90% have periodontal disease.” However,
with increasing affluence of the Chinese population, as well as increasing
attention towards personal care, demand for dental services has been
growing. Market research firm Freedonia agrees, noting that demand
for dental products in China is expected to climb to 21.5 billion RMB
(US$3.15 billion) by 2012, due primarily to escalating personal income
levels and government programs promoting awareness of the benefits of
good oral care.
Continuing, Osser said, “In view of the prevailing size and scope
of the market opportunity in China, being driven by a growing emphasis
on proactive dental care for China’s citizens, Sinopharm should
prove to be well placed geographically in Milestone’s global market
penetration strategy.”
The patented, award-winning STA System is
a computer-controlled, pressure-sensitive injection system, which provides
dentists with audible and visual signals as to in-tissue pressure and
needle location. Milestone’s
latest achievement in computer-controlled local anesthesia delivery makes
the injection process more comfortable for both dentists and patients
and allows for the painless delivery of local anesthetic. In addition
to its general use for all dental injections, the STA System is
uniquely capable of predictably and more comfortably administering “Single
Tooth Anesthesia” into the Periodontal Intraligamentary (PDL) space,
something never before possible using conventional techniques. This injection
results in the patient having no collateral numbness and no pain along
with instant, predictable anesthesia. The benefit of this injection
with the STA instrument is significant for the patient, the
dentist and the business of dentistry.
“This major order from Sinopharm, coupled with anticipated recurring
hand piece sales to its customers, unequivocally strengthens Milestone’s
growth prospects in the Asian market and supports one of our key long term
objectives – establishing the STA System as the universal
standard of care for dental injections,” stated Leslie Bernhard,
Milestone’s Chairman. “Moreover, we are confident that
this continued success for our STA System will have a resounding
impact on our Company’s global industry standing.”
About Milestone Scientific Inc.
Headquartered in Piscataway, New Jersey, Milestone Scientific is engaged
in pioneering proprietary, highly innovative technological solutions
for the medical and dental markets. Central to the Company’s
IP platform and product development strategy is its patented CompuFlo® technology
for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is
a computer-controlled, pressure sensitive infusion, perfusion, suffusion
and aspiration technology, which provides real-time readouts of pressures,
fluid densities and flow rates, enabling the advanced delivery and
removal of a wide array of fluids. The STA Single
Tooth Anesthesia System™, a computer-controlled local anesthesia
delivery system, uses this technology to provide dentists with audible
and visual signals as to in-tissue pressure. Milestone’s
existing painless injection systems are currently sold in 25 countries. For
more information on these and other innovative Milestone products,
please visit the Company’s web site found at www.milestonescientific.com and www.STAis4U.com.
FOR MORE INFORMATION, PLEASE CONTACT:
Elite Financial Communications Group
Dodi Handy, President and CEO
For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors, Elite
Media Group
407-585-1080 or via email at mlss@efcg.net
|
